Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.400
+0.010 (0.72%)
Aug 21, 2026, 10:47 AM EDT - Market open
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,014,755
Market Cap
5.15M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 6 | 0 | - | 5 | 1 |
| Dec 31, 2024 | 6 | -1 | -14.29% | 5 | 1 |
| Dec 31, 2023 | 7 | -19 | -73.08% | 7 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 25 | 1 |
| Dec 31, 2021 | 24 | 21 | 700.00% | 23 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| CollPlant Biotechnologies | 39 |
| GeoVax Labs | 19 |
| BioRestorative Therapies | 14 |
| Processa Pharmaceuticals | 12 |
| Dermata Therapeutics | 9 |
| Cadrenal Therapeutics | 5 |
| Silo Pharma | 3 |
ENVB News
- 6 days ago - Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026 - Business Wire
- 16 days ago - Enveric Biosciences reports new preclinical data on EB-003 - TheFly
- 16 days ago - Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003 - Business Wire
- 24 days ago - Enveric ‘welcomes’ final FDA guidance for psychedelic drug development - TheFly
- 24 days ago - Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development - Business Wire
- 7 weeks ago - Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit - Business Wire
- 2 months ago - Enveric Biosciences Announces Participation in 2026 BIO International Convention - Business Wire
- 2 months ago - Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day - Business Wire